This spectrum of somatic mutations in NTHL1-het tumors was similar to that observed in sporadic breast cancer, with mutations in TP53 and PIK3CA the most common, and mutations in MAP3K1 and GATA3 frequently occurring in ER+ cancers14. This evidence concerns the gene NTHL1 and breast carcinoma.